Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital
Abstract Background Procalcitonin (PCT) is a useful marker for pneumonia. However, its clinical usefulness in elderly patients has not been studied extensively. This study aimed to assess the relationship between PCT and prognosis and pneumonia severity in elderly patients with pneumonia acquired ou...
Main Authors: | Takanori Akagi, Nobuhiko Nagata, Hiroyuki Miyazaki, Taishi Harada, Satoshi Takeda, Yuji Yoshida, Kenji Wada, Masaki Fujita, Kentaro Watanabe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | BMC Geriatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12877-018-1008-8 |
Similar Items
-
Procalcitonin: in Lobar and Non-Lobar Pneumonia in Children
by: Farhad Heydarian, et al.
Published: (2018-07-01) -
Performance of serum procalcitonin for diagnosing bacterial pneumonia in patients with chronic interstitial lung disease
by: Eman Shebl, et al.
Published: (2020-01-01) -
Procalcitonin for detecting community-acquired bacterial pneumonia
by: Devi Gusmaiyanto, et al.
Published: (2015-04-01) -
Value of procalcitonin as a biomarker for postoperative hospital-acquired pneumonia after abdominal surgery
by: Mohamed M Abu Elyazed, et al.
Published: (2017-04-01) -
Diagnostic accuracy of lung ultrasonography combined with procalcitonin for the diagnosis of pneumonia: a pilot study
by: Peiman Nazerian, et al.
Published: (2016-11-01)